{
    "code": "02025515",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025515",
    "time": "2017-01-06 03:04:49",
    "許可證字號": "衛署藥輸字第025515號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/08\/24",
    "發證日期": "100\/08\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202551501",
    "中文品名": "宜平素&quot;山德士&quot;靜脈注射劑2毫克\/毫升",
    "英文品名": "Epirubicin &quot;Ebewe&quot; 2mg\/ml concentrate for solution for infusion",
    "適應症": "乳腺癌、惡性淋巴瘤、軟組織肉瘤、胃癌、肺癌、卵巢瘤。",
    "劑型": "270注射劑",
    "包裝": "5毫升、25毫升小瓶裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "EPIRUBICINHCL"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "1309306200  臺灣諾華股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F030024000  EBEWE PHARMA GES.M.B.H.NFG. KG",
        "製造廠廠址": "MONDSEESTRABE 11,A-4866 UNTERACH,AUSTRIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012000910",
            "成分名稱": "EPIRUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_TWI-050315-104-09-29(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=005&Type=9"
        },
        {
            "title": "仿單02025515-104-03-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=004&Type=9"
        },
        {
            "title": "Leaflet_20140414 updated-2014-04-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=003&Type=9"
        },
        {
            "title": "Epirugicin Ebewe 2mg1ml English PI___20110927.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=002&Type=9"
        },
        {
            "title": "Epirubicin Chinese PI___20110927.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=001&Type=9"
        },
        {
            "title": "FB (50mg25ml)-104-09-29(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=007&Type=8"
        },
        {
            "title": "FB (10mg5ml)-104-09-29(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=006&Type=8"
        },
        {
            "title": "Epirubicin Ebewe Chinese Label___20110927.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=005&Type=8"
        },
        {
            "title": "Epirubicin Ebewe 50mg25ml English label___20110927.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=004&Type=8"
        },
        {
            "title": "Epirubicin Ebewe 50mg25ml English folding box___20110927.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=003&Type=8"
        },
        {
            "title": "Epirubicin Ebewe 10mg5ml English label___20110927.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=002&Type=8"
        },
        {
            "title": "Epirubicin Ebewe 10mg5ml English folding box___20110927.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025515&Seq=001&Type=8"
        }
    ]
}